This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sanofi-Aventis Recherche & Développement. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Laurence Lucats - Innovator in Therapeutic Applications
Introduction
Laurence Lucats is an inventor based in Paris, France. He is currently associated with Sanofi, a global healthcare company. Although he has not yet been granted any patents, his work focuses on innovative therapeutic applications.
Latest Patent Applications
Laurence Lucats has submitted a patent application titled "CRF2 Receptor Agonists and Their Use in Therapy." This application presents compounds that are peptides comprising a specific amino acid sequence or pharmaceutically acceptable salts thereof. The compounds are designed to act as agonists of the corticotropin-releasing factor receptor 2 (CRF2) and are particularly useful in the treatment or prevention of cardiovascular diseases, obesity, and diabetes.
Conclusion
Laurence Lucats is making significant contributions to the field of therapeutic innovations, particularly through his research on CRF2 receptor agonists. His work holds promise for addressing critical health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile